These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 35008556)

  • 1. The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases.
    Paluszkiewicz P; Martuszewski A; Zaręba N; Wala K; Banasik M; Kepinska M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines for kidney diseases.
    Williams RM; Jaimes EA; Heller DA
    Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zinc oxide nanoparticles and ferulic acid on renal ischemia/reperfusion injury: possible underlying mechanisms.
    Awadalla A; Hussein AM; El-Far YM; Barakat N; Hamam ET; El-Sherbiny M; El-Shafey M; Shokeir AA
    Biomed Pharmacother; 2021 Aug; 140():111686. PubMed ID: 34015581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.
    Lee SH; Lee JB; Bae MS; Balikov DA; Hwang A; Boire TC; Kwon IK; Sung HJ; Yang JW
    Adv Healthc Mater; 2015 Sep; 4(13):2037-45. PubMed ID: 26121684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanotherapy for kidney diseases: a comprehensive review.
    Sabiu G; Kasinath V; Jung S; Li X; Tsokos GC; Abdi R
    Nephrol Dial Transplant; 2023 May; 38(6):1385-1396. PubMed ID: 35945647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.
    Wang J; Masehi-Lano JJ; Chung EJ
    Biomater Sci; 2017 Jul; 5(8):1450-1459. PubMed ID: 28516997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.
    Huang Y; Wang J; Jiang K; Chung EJ
    J Control Release; 2021 Jun; 334():127-137. PubMed ID: 33892054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological principles underlying the kidney targeting of renal nanomedicines.
    Huang Y; Ning X; Ahrari S; Cai Q; Rajora N; Saxena R; Yu M; Zheng J
    Nat Rev Nephrol; 2024 Jun; 20(6):354-370. PubMed ID: 38409369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of nanotechnology in kidney transplantation.
    Li S; Chen Y; Cao X; Yang C; Li W; Shen B
    Nanomedicine (Lond); 2024 Feb; 19(5):413-429. PubMed ID: 38275168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.
    Liu CP; Hu Y; Lin JC; Fu HL; Lim LY; Yuan ZX
    Med Res Rev; 2019 Mar; 39(2):561-578. PubMed ID: 30136283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology Applications in Transplantation Medicine.
    Yao CG; Martins PN
    Transplantation; 2020 Apr; 104(4):682-693. PubMed ID: 31651794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnological foundations of a «new» Nephrology.
    Soriano ML; Rodríguez-Benot A; Valcárcel M
    Nefrologia (Engl Ed); 2018; 38(4):368-378. PubMed ID: 29778557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury.
    Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J
    Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis.
    Yu H; Lin T; Chen W; Cao W; Zhang C; Wang T; Ding M; Zhao S; Wei H; Guo H; Zhao X
    Biomaterials; 2019 Oct; 219():119368. PubMed ID: 31349200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia/reperfusion injury by inhibiting cell apoptosis and inflammation.
    Xu Y; Zhang B; Xie D; Hu Y; Li HL; Zhong LL; Wang HW; Jiang W; Ke ZP; Zheng DH
    Oncotarget; 2017 Jun; 8(24):39547-39558. PubMed ID: 28465474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.